Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02372773 · ClinicalTrials.gov registry record
Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects
A clinical trial of Familial Frontotemporal Dementia, sponsored by Mayo Clinic.
- Completed
- Registry status
- 398
- Enrollment target
- 8
- Study locations
NCT02372773 is a study of Familial Frontotemporal Dementia that has completed, run by Mayo Clinic. The registered enrollment target is 398 participants. The trial reports 8 study locations across 8 states.
The verdict
NCT02372773, a study of Familial Frontotemporal Dementia, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 398 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study is being done to learn more about normal thinking and behavior, mild thinking and behavior problems, Frontotemporal Dementia and other forms of dementia in families in which one or more relatives have a mutation associated with Frontotemporal Dementia.
Conditions Studied
Study Locations (8)
California
- University of California, San Francisco, Memory and Aging Center, Department of Neurology - San Francisco
Florida
- Mayo Clinic Florida - Jacksonville
Massachusetts
- Harvard University - Charlestown
Minnesota
- Mayo Clinic - Rochester
Missouri
- Washington University - St Louis
New York
- Columbia University - New York
Pennsylvania
- Univerisity of Pennsylvania - Philadelphia
British Columbia
- University of British Columbia - Vancouver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 398 participants |
| Start Date | 2015-04 |
| Est. Completion | 2020-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02372773
The ClinicalTrials.gov registry entry for NCT02372773 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 398 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Familial Frontotemporal Dementia appearing as the primary indexed condition, and to 0 interventions.
NCT02372773 reports 8 study locations spanning 8 distinct geographic areas - top geographies include California, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02372773 about?
NCT02372773 is a clinical study titled "Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects". This study is being done to learn more about normal thinking and behavior, mild thinking and behavior problems, Frontotemporal Dementia and other forms of dementia in families in which one or more relatives have a mutation associated with Frontotemporal Dementia.
What is the current status of trial NCT02372773?
This trial is currently completed. The enrollment target is 398 participants. The study started on 2015-04. Estimated completion is 2020-06-30.
What conditions does trial NCT02372773 study?
This clinical trial studies the following conditions: Familial Frontotemporal Dementia.
Who is sponsoring clinical trial NCT02372773?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02372773 being conducted?
This trial has 8 study locations across California, Florida, Massachusetts, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.